1470 — Evertex Fabrinology Income Statement
0.000.00%
- TWD2.22bn
- TWD1.85bn
- TWD788.04m
- 82
- 43
- 60
- 70
Annual income statement for Evertex Fabrinology, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 631 | 895 | 845 | 655 | 788 |
Cost of Revenue | |||||
Gross Profit | 114 | 191 | 174 | 130 | 199 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 612 | 815 | 777 | 621 | 700 |
Operating Profit | 19 | 79.6 | 68.4 | 34.4 | 87.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 40.8 | 78.7 | 50 | 57.2 | 121 |
Provision for Income Taxes | |||||
Net Income After Taxes | 35.4 | 65.2 | 32.8 | 49.3 | 97.3 |
Net Income Before Extraordinary Items | |||||
Net Income | 35.4 | 65.2 | 32.8 | 49.3 | 97.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 35.4 | 65.2 | 32.8 | 49.3 | 97.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.403 | 0.748 | 0.382 | 0.575 | 1.13 |
Dividends per Share |